SCHEMBL21377946

SCHEMBL21377946

N#Cc1c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c(-c2ccccc2-n2c3ccccc3c3ccccc32)c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c1-n1c2ccccc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.34
PDE9A O76083 1/20 0.33
PDE1C Q14123 1/20 0.33
HTR3A P46098 1/20 0.33
PARP1 P09874 1/20 0.33
ALDH1A1 P00352 6/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
KDM4E B2RXH2 4/20 0.31
RXFP1 Q9HBX9 2/20 0.31
LMNA P02545 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
NCOA3 Q9Y6Q9 1/20 0.31
POLB P06746 1/20 0.31
MAPK1 P28482 2/20 0.31
STAT3 P40763 1/20 0.31
HPGD P15428 2/20 0.31
MAPT P10636 1/20 0.31
CASP1 P29466 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21378080 0.91 CYP11B2 (0.36) TSPOKDM4ENPY5RGAA
SCHEMBL21378045 0.91 CYP11B2 (0.36) KDM4ENPY5RGAA
SCHEMBL21378018 0.91 CYP11B2 (0.36) KDM4ENPY5RGAA
SCHEMBL21396891 0.91 CYP11B2 (0.36) KDM4ENPY5RGAA
SCHEMBL21378034 0.91 CYP11B2 (0.36) TSPOKDM4ENPY5RGAA
SCHEMBL20596186 0.90 PDE9A (0.35) TSPOPDE9APDE1CHTR3APARP1
SCHEMBL20596032 0.88 PDE9A (0.39) TSPOPDE9APDE1CHTR3APARP1
SCHEMBL22250955 0.88 PDE9A (0.39) TSPOPDE9APDE1CHTR3APARP1
SCHEMBL22251505 0.88 PDE9A (0.39) TSPOPDE9APDE1CHTR3APARP1
SCHEMBL21765780 0.88 PDE9A (0.39) TSPOPDE9APDE1CHTR3APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11608333-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-03-21 US disclosed
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 TSPO 1797/4885PDE9A 4069/4885PDE1C 4875/4885
US-11608333-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 TSPO 1797/4885PDE9A 4069/4885PDE1C 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.